Pilot Deprescribing Trials for Beta-blockers in Cardiac Amyloidosis
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators will test the feasibility of N-of-1 trials for deprescribing
beta-blockers in patients with Cardiac Amyloidosis. To achieve this objective, 16 N-of-1
trials (on vs. off) will be conducted and subsequently interview participants to better
understand feasibility and pragmatism. Each subject can participate in a total of up to 4
periods lasting between 2-6 weeks each based on each patients' health profile. The N-of-1
trials will be iteratively refined in real-time based on feedback.